EUVIMEDEUVIMED entdecken
Open Access

Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach

Jingtao Wei, Ke Ji, Yue Zhang, Ji Zhang, Xiaojiang Wu, Xin Ji, Kai Zhou, Xuesong Yang, Hongfeng Lu, Anqiang Wang, Zhaode Bu

Cellular Oncology · 2024

DOI: 10.1007/s13402-023-00892-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Jingtao Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Center, Peking Uni…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science Foundation of Peking University Cancer Hospital, Capital's Funds For Health Improvement and Research, Beijing Youth Talent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorAdenocarcinomaHumansMaleFemaleMiddle AgedAgedMutationGene Expression Regulation, NeoplasticExome SequencingTreatment OutcomeRetrospective StudiesAdultTranscriptome

Stichwörter der Autor:innen

GenomeHepatoid adenocarcinomaPreoperative chemotherapyTranscriptome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian Dist…
  • Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Animal Experimental Centre, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beiji…
  • The Cardiomyopathy Research Group at Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Beijing, 100037, China.
  • Berry Genomics Corporation, Beijing, 102206, China.

Förderung

  • Science Foundation of Peking University Cancer Hospital
  • Capital's Funds For Health Improvement and Research
  • Beijing Youth Talent Plan
  • Capital’s Funds For Health Improvement and Research

Zitieren

APA

Wei, J., Ji, K., Zhang, Y., Zhang, J., Wu, X., Ji, X., Zhou, K., Yang, X., Lu, H., Wang, A., & Bu, Z. (2024). Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular Oncology. https://doi.org/10.1007/s13402-023-00892-9

Vancouver

Wei J, Ji K, Zhang Y, Zhang J, Wu X, Ji X, et al. Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular Oncology. 2024. doi:10.1007/s13402-023-00892-9

BibTeX
@article{Wei2024,
  author = {Wei, Jingtao and Ji, Ke and Zhang, Yue and Zhang, Ji and Wu, Xiaojiang and Ji, Xin and Zhou, Kai and Yang, Xuesong and Lu, Hongfeng and Wang, Anqiang and Bu, Zhaode},
  title = {Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-023-00892-9}
}
Kostenlos starten →